Min Ji Selected Research

Ocular Hypertension (Glaucoma, Suspect)

7/2023	ATP-P2X7R-mediated microglia senescence aggravates retinal ganglion cell injury in chronic ocular hypertension.
11/2019	Activation of P2X7R- NLRP3 pathway in Retinal microglia contribute to Retinal Ganglion Cells death in chronic ocular hypertension (COH).
1/2018	Dopamine D1 receptor-mediated upregulation of BKCa currents modifies Müller cell gliosis in a rat chronic ocular hypertension model.
12/2016	Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells.
9/2012	Group I mGluR-mediated inhibition of Kir channels contributes to retinal Müller cell gliosis in a rat chronic ocular hypertension model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Ji Research Topics

Disease

46	Neoplasms (Cancer) 02/2024 - 09/2003
12	Cataract (Cataracts) 02/2024 - 01/2019
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 01/2012
8	Leukemia 01/2023 - 03/2008
7	AIDS-Related Complex (ARC) 12/2023 - 01/2022
6	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2012
5	Parkinson Disease (Parkinson's Disease) 11/2023 - 01/2022
5	Ocular Hypertension (Glaucoma, Suspect) 07/2023 - 09/2012
5	Breast Neoplasms (Breast Cancer) 12/2022 - 12/2013
5	Shock 10/2022 - 01/2016
5	Hemorrhage 11/2019 - 09/2003
4	Gliosis 01/2018 - 09/2012
3	Inflammation (Inflammations) 03/2024 - 01/2015
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023 - 01/2020
3	Glaucoma 07/2023 - 12/2013
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2022
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023 - 01/2022
3	Glioma (Gliomas) 01/2022 - 11/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 01/2012
3	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 01/2007
2	Abdominal Aortic Aneurysm 03/2024 - 11/2019
2	Arthrogryposis renal dysfunction cholestasis syndrome 12/2023 - 10/2022
2	Epiretinal Membrane (Epiretinal Membranes) 11/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 01/2019
2	Pathologic Complete Response 01/2023 - 05/2012
2	Pathologic Processes 10/2022 - 05/2016
2	Dyskinesias (Dyskinesia) 06/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 08/2019
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2021
2	Hyperthermia 06/2020 - 01/2020
2	Carcinogenesis 01/2020 - 02/2009
2	Astigmatism 01/2020 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 08/2015
2	Hyperlipidemias (Hyperlipidemia) 04/2018 - 07/2015
2	Hypoxia (Hypoxemia) 01/2016 - 11/2006
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2015 - 01/2012
2	Starvation 09/2014 - 11/2008
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2014 - 06/2011

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2004
7	Retinaldehyde (Retinal)IBA 07/2023 - 09/2012
5	CytokinesIBA 01/2022 - 01/2012
4	Interleukin-10 (Interleukin 10)IBA 11/2023 - 05/2012
4	Messenger RNA (mRNA)IBA 11/2023 - 01/2020
4	MicroRNAs (MicroRNA)IBA 11/2023 - 02/2009
4	Liposomes (Liposome)IBA 01/2023 - 01/2019
4	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023 - 04/2017
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 06/2011
4	GossypolIBA 08/2015 - 11/2004
3	Long Noncoding RNAIBA 03/2024 - 11/2023
3	Capsules (Microcapsules)IBA 11/2023 - 06/2020
3	LipidsIBA 01/2023 - 07/2015
3	Peptides (Polypeptides)IBA 01/2023 - 09/2005
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2022
3	Levodopa (L Dopa)FDA LinkGeneric 06/2022 - 01/2022
3	LigandsIBA 01/2022 - 04/2017
3	EnzymesIBA 10/2020 - 05/2012
3	ProdrugsIBA 01/2020 - 03/2014
3	AntigensIBA 01/2020 - 03/2008
3	Glial Fibrillary Acidic ProteinIBA 01/2018 - 09/2012
2	HMGB1 Protein (HMG1)IBA 03/2024 - 07/2014
2	RNA (Ribonucleic Acid)IBA 12/2023 - 08/2015
2	6-methyladenineIBA 12/2023 - 01/2023
2	N-methyladenosineIBA 12/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 11/2023 - 06/2022
2	Opioid Analgesics (Opioids)IBA 10/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 01/2005
2	thiamine triphosphorate (TTP)IBA 03/2023 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2015
2	VaccinesIBA 01/2022 - 06/2007
2	Dopamine D3 ReceptorsIBA 01/2022 - 01/2021
2	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 01/2021
2	Naloxone (Narcan)FDA LinkGeneric 01/2022 - 01/2021
2	chromium hexavalent ionIBA 10/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 05/2012
2	Heavy MetalsIBA 01/2021 - 01/2016
2	Hormones (Hormone)IBA 01/2021 - 07/2008
2	Ferrosoferric Oxide (Magnetite)FDA Link 06/2020 - 04/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2019
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020 - 08/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 11/2018
2	AcidsIBA 01/2020 - 11/2018
2	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 02/2016
2	WastewaterIBA 01/2017 - 11/2008
2	Chemokine ReceptorsIBA 01/2017 - 01/2015
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 12/2016 - 01/2016
2	3,4-dihydroxyphenylglycolIBA 12/2016 - 01/2016
2	ImmunosorbentsIBA 01/2015 - 05/2012
2	Dasatinib (BMS 354825)FDA Link 05/2013 - 01/2012
2	Gefitinib (Iressa)FDA Link 12/2011 - 06/2010
1	Nanoparticle Drug Delivery SystemIBA 02/2024

Therapy/Procedure

16	Therapeutics 02/2024 - 09/2003
12	Drug Therapy (Chemotherapy) 11/2023 - 11/2004
4	Phacoemulsification 02/2024 - 01/2019
3	Lasers (Laser) 02/2024 - 01/2020
3	Radiotherapy 06/2022 - 03/2016
3	Intravitreal Injections 01/2018 - 01/2016
2	Enterostomy 11/2023 - 01/2020
2	Induction Chemotherapy 01/2023 - 11/2022
2	Photothermal Therapy 11/2022 - 05/2022
2	Stents 01/2021 - 11/2019